10561310

Source:http://linkedlifedata.com/resource/pubmed/id/10561310

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0751606, umls-concept:C2728259
pubmed:issue	8
pubmed:dateCreated	2000-1-6
pubmed:abstractText	To evaluate response and outcome with a front-line intensive multiagent chemotherapy regimen in adults with Burkitt's-type acute lymphoblastic leukemia (B-ALL).
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8309333
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide, http://linkedlifedata.com/resource/pubmed/chemical/Dexamethasone, http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin, http://linkedlifedata.com/resource/pubmed/chemical/Vincristine
pubmed:status	MEDLINE
pubmed:month	Aug
pubmed:issn	0732-183X
pubmed:author	pubmed-author:AlbitarMM, pubmed-author:CabanillasF FFF, pubmed-author:CortesJJ, pubmed-author:FaderlSS, pubmed-author:HagemeisterF BFB, pubmed-author:KantarjianHH, pubmed-author:KeatingM JMJ, pubmed-author:MurphySS, pubmed-author:O'BrienSS, pubmed-author:PierceSS, pubmed-author:ThomasD ADA
pubmed:issnType	Print
pubmed:volume	17
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	2461-70
pubmed:dateRevised	2006-4-24
pubmed:meshHeading	pubmed-meshheading:10561310-Adolescent, pubmed-meshheading:10561310-Adult, pubmed-meshheading:10561310-Aged, pubmed-meshheading:10561310-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:10561310-Burkitt Lymphoma, pubmed-meshheading:10561310-Cyclophosphamide, pubmed-meshheading:10561310-Dexamethasone, pubmed-meshheading:10561310-Doxorubicin, pubmed-meshheading:10561310-Female, pubmed-meshheading:10561310-Humans, pubmed-meshheading:10561310-Karyotyping, pubmed-meshheading:10561310-Male, pubmed-meshheading:10561310-Middle Aged, pubmed-meshheading:10561310-Regression Analysis, pubmed-meshheading:10561310-Risk Factors, pubmed-meshheading:10561310-Salvage Therapy, pubmed-meshheading:10561310-Survival Rate, pubmed-meshheading:10561310-Time Factors, pubmed-meshheading:10561310-Treatment Outcome, pubmed-meshheading:10561310-Vincristine
pubmed:year	1999
pubmed:articleTitle	Hyper-CVAD program in Burkitt's-type adult acute lymphoblastic leukemia.
pubmed:affiliation	Departments of Leukemia, Hematopathology, and Lymphoma, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
pubmed:publicationType	Journal Article, Clinical Trial